Age | ≤29 | 30-39 | 40-49 | 50-59 | 60-69 | 70+ | |
---|---|---|---|---|---|---|---|
Men | |||||||
Normal | prevalence | 6.0 | 10.9 | 13.2 | 21.5 | 12.8 | 11.8 |
persons at risk | 1042 | 2338 | 1731 | 1235 | 704 | 152 | |
Prediabetes | |||||||
prevalence | 9.1 | 16.3 | 15.5 | 23.3 | 16.9 | 12.1 | |
persons at risk | 22 | 270 | 555 | 738 | 350 | 66 | |
Diabetes | |||||||
prevalence | __ | 11.8 | 19.1 | 43.7 | 26.9 | 20.3 | |
persons at risk | 2 | 51 | 110 | 263 | 193 | 59 | |
χ2value for linear trend (p-value) | __ | 4.25 (0.039) | 4.31 (0.038) | 39.9 (0.000) | 21.16 (0.000) | 2.14 (0.144) | |
Women | |||||||
Normal | prevalence | 5.9 | 14.8 | 11.6 | 19.8 | 23.2 | 33.9 |
persons at risk | 892 | 2657 | 2340 | 2235 | 711 | 112 | |
Prediabetes | |||||||
prevalence | __ | 16.9 | 12.4 | 21.9 | 23.3 | 30.5 | |
persons at risk | 11 | 413 | 728 | 1184 | 361 | 59 | |
Diabetes | |||||||
prevalence | __ | __ | 20.3 | 37.7 | 42.1 | __ | |
persons at risk | 2 | 19 | 59 | 159 | 76 | 15 | |
χ2value for linear trend (p-value) | __ | __ | 2.12 (0.145) | 17.53 (0.000) | 6.24 (0.012) | __ |